NE3107 in Adults With Neurological Symptoms of Long COVID

PHASE2RecruitingINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

April 29, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

January 31, 2026

Conditions
Long COVID
Interventions
DRUG

NE3107

20 mg Capsule

DRUG

Placebo

placebo capsule

Trial Locations (13)

20904

RECRUITING

Jadestone Clinical Research, Silver Spring

26506

RECRUITING

West Virginia University, Morgantown

31904

RECRUITING

Centricity Research, Columbus

32258

RECRUITING

Clinical Trial Site, Jacksonville

40202

RECRUITING

Norton Infectious Disease Institute, Louisville

44106

RECRUITING

University Hospitals Cleveland Medical Center, Cleveland

48334

RECRUITING

Clinical Trial Site, Farmington Hills

52242

RECRUITING

University of Iowa, Iowa City

60608

RECRUITING

Illinois Research Network University of Illinois at Chicago, Chicago

75230

RECRUITING

Zenos Clinical Research, Dallas

78229

RECRUITING

University of Texas health Science Center at San Antonio, San Antonio

80045

RECRUITING

University of Colorado, Aurora

94110

NOT_YET_RECRUITING

Clinical Trial Site, San Francisco

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BioVie Inc.

INDUSTRY